A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Message: AGORACOM Small Cap 60: Valeo Pharma Is A Commercial Stage, Revenue Generating Company With Q3 Revenue of $5.7M
Reply New Message
Prev Message Back To Forum Threaded View Next Message

AGORACOM Small Cap 60: Valeo Pharma Is A Commercial Stage, Revenue Generating Company With Q3 Revenue of $5.7M

posted on Sep 27, 2021 03:08PM
Log in to use the IP Check tool [?]

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply